What does an NT‑pro‑BNP level of 3973 pg/mL with a left ventricular ejection fraction of 57 % on a two‑dimensional echocardiogram indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Elevated NT-proBNP with Preserved Ejection Fraction: Heart Failure with Preserved Ejection Fraction (HFpEF)

An NT-proBNP of 3973 pg/mL with an ejection fraction of 57% most likely indicates heart failure with preserved ejection fraction (HFpEF), where the heart muscle is stiff and unable to relax properly despite maintaining normal pumping function. 1

Understanding the Apparent Discrepancy

This combination is not contradictory—it's actually a classic presentation of HFpEF. Here's the algorithmic approach to interpretation:

Why NT-proBNP is Elevated Despite Normal EF

NT-proBNP reflects total cardiac stress, not just systolic function. The peptide is released in response to:

  • Elevated left ventricular filling pressures (diastolic dysfunction)
  • Increased ventricular wall stress
  • Volume or pressure overload
  • Right ventricular dysfunction
  • Atrial stretch (especially with atrial fibrillation)

1, 2

In HFpEF, the left ventricle has normal contractility (preserved EF ≥50%) but impaired relaxation, leading to elevated filling pressures that trigger NT-proBNP release. The guideline evidence confirms that BNP levels are elevated in patients with diastolic dysfunction even when systolic function is preserved 1.

Diagnostic Interpretation Algorithm

With NT-proBNP of 3973 pg/mL:

  1. This level far exceeds diagnostic thresholds for heart failure:

    • Cutoff for ruling in HF: >450 pg/mL (age <50) or >900 pg/mL (age ≥50) 1
    • Your value of 3973 pg/mL is 4-8 times higher than diagnostic thresholds

  2. With EF of 57%, this classifies as HFpEF (EF ≥50%) 3

  3. The elevation magnitude suggests significant cardiac dysfunction despite preserved systolic function 4

Clinical Implications and Next Steps

Confirm HFpEF Diagnosis

Look for these supporting features:

  • Symptoms: Dyspnea, exercise intolerance, fatigue, lower extremity edema
  • Signs: Elevated jugular venous pressure, pulmonary rales, peripheral edema
  • Risk factors: Hypertension, obesity, diabetes, atrial fibrillation, age >60 years 3

Echocardiographic Diastolic Assessment Required

The 2-D echo report should include:

  • E/e' ratio (tissue Doppler): E/e' >9 suggests elevated filling pressures 3
  • Left atrial enlargement: Common in HFpEF
  • Pulmonary artery systolic pressure: Often elevated (>35 mmHg) 3
  • Transmitral flow patterns: Assess diastolic function grade

Critical pitfall: A routine echo reporting only EF is insufficient for HFpEF diagnosis—specific diastolic parameters must be evaluated 2.

Alternative Causes to Consider

Before finalizing HFpEF diagnosis, exclude other conditions that elevate NT-proBNP with preserved EF:

Cardiac causes:

  • Atrial fibrillation: Can independently elevate NT-proBNP 2
  • Significant valvular disease: Especially mitral regurgitation or aortic stenosis 2
  • Right ventricular dysfunction: From pulmonary hypertension or pulmonary embolism 2
  • Acute coronary syndrome: Even without reduced EF

Non-cardiac causes:

  • Renal dysfunction: NT-proBNP levels are 4-fold higher with eGFR <60 mL/min/1.73m² 2
  • Pulmonary disease: COPD, pulmonary embolism 1, 2
  • Sepsis: Can produce comparable NT-proBNP elevations 2
  • Advanced age: NT-proBNP increases ~10-20 pg/mL per decade 2, 5

Important caveat: Check renal function (creatinine, eGFR). If eGFR <60, the NT-proBNP threshold for HF diagnosis should be adjusted upward, though 3973 pg/mL remains significantly elevated even accounting for renal impairment 2, 6.

Prognostic Significance

This NT-proBNP level carries poor prognosis. In HFpEF patients, NT-proBNP >1035 pg/mL confers a >4-fold increased risk of mortality or HF hospitalization 7. Your patient's level of 3973 pg/mL places them at very high risk and warrants aggressive management.

Management Approach for HFpEF

Unlike HFrEF, treatment options are more limited:

  • SGLT2 inhibitors: First-line therapy showing mortality benefit 8
  • Diuretics: For volume management and symptom relief
  • Blood pressure control: Target <130/80 mmHg
  • Treat atrial fibrillation if present
  • Manage comorbidities: Diabetes, obesity, sleep apnea

The combination of markedly elevated NT-proBNP with preserved EF should prompt comprehensive evaluation for HFpEF, including detailed diastolic function assessment and exclusion of alternative diagnoses, particularly renal dysfunction and atrial fibrillation.

References

Related Questions

In a patient aged 75 years or older with an NT‑proBNP level of 447 pg/mL (within the age‑adjusted reference range), how should this result be interpreted and what are the recommended next steps for evaluation and management?
In a patient with massive ascites due to an ovarian tumor and a preserved left ventricular ejection fraction, can the ascites cause an elevated N‑terminal pro‑B‑type natriuretic peptide (NT‑proBNP) level?
In a 73-year-old man with a BNP of 968 pg/mL, grade 1 diastolic dysfunction, and a left‑ventricular ejection fraction (EF) of 60‑65 %, does this indicate heart failure?
What does an elevated NT‑proBNP indicate in a 73‑year‑old man with a preserved ejection fraction of 60‑65% and grade 1 diastolic dysfunction?
How should I manage a patient with a B-type natriuretic peptide (BNP) less than 5 pg/mL who presents with dyspnea and peripheral edema, has chronic kidney disease (creatinine 1.7 mg/dL), peripheral arterial disease, and a serum potassium of 5.1 mmol/L?
In an 8-year-old with a displaced mid‑shaft fracture of the right clavicle 10 days after injury, what is the initial treatment?
What are the potential complications of a celiac plexus block?
What is the most likely diagnosis in a 9-year-old girl who developed fever followed by loss of consciousness, with MRI showing bilateral patchy basal ganglia lesions, mild lymphocytic CSF pleocytosis, and who improved with intravenous immunoglobulin (IVIG) and intravenous methylprednisolone (MP)?
What definitive external-beam radiation dose and fractionation schedule should be used for a 4 cm squamous cell carcinoma?
In a patient with attention‑deficit/hyperactivity disorder and depression who previously experienced mood dysregulation on bupropion (Wellbutrin), should I be concerned about initiating a stimulant medication?
What is the appropriate management and treatment for breakthrough bleeding in a patient taking Feirza (ethinyl estradiol/levonorgestrel) white active oral contraceptive tablets?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.